114Mg Pyrantel Pamoate/ 114Mg Praziquantel

Verify with FDA CVM →

91 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
91
Total Reports
9
Deaths Reported
990.0%
Death Rate

Active Ingredients

114Mg Pyrantel Pamoate/ 114Mg Praziquantel

Administration Routes

OralUnknown

Species Affected

Dog 88
Human 2
Unknown 1

Most Affected Breeds

Retriever - Labrador 14
American Pit Bull Terrier 12
Dog (unknown) 9
Retriever - Golden 4
Rottweiler 3
Boxer (German Boxer) 3
Unknown 3
Collie - Border 3
Beagle 3
Chihuahua 3

Most Reported Reactions

Vomiting 41
Lethargy (see also Central nervous system depression in 'Neurological') 19
Diarrhoea 13
Ataxia 7
Digestive tract disorder NOS 7
Anorexia 6
Not eating 6
Behavioural disorder NOS 5
Death by euthanasia 5
Overdose 5
Decreased appetite 4
Trembling 4

Outcome Breakdown

Outcome Unknown
41 (44.6%)
Recovered/Normal
41 (44.6%)
Euthanized
5 (5.4%)
Died
4 (4.3%)
Ongoing
1 (1.1%)

Data Summary

Metric Value
Total adverse event reports 91
Reports involving death 9
Case-fatality rate (reported events) 990.0%
Distinct species in reports 3
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

114Mg Pyrantel Pamoate/ 114Mg Praziquantel Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 91 adverse event reports referencing 114Mg Pyrantel Pamoate/ 114Mg Praziquantel, including 9 reports in which the animal died — a 990.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: 114Mg Pyrantel Pamoate/ 114Mg Praziquantel. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in 114Mg Pyrantel Pamoate/ 114Mg Praziquantel reports are Dog (88 reports), Human (2 reports), Unknown (1 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (14), American Pit Bull Terrier (12), Dog (unknown) (9) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with 114Mg Pyrantel Pamoate/ 114Mg Praziquantel are Vomiting (41), Lethargy (see also Central nervous system depression in 'Neurological') (19), Diarrhoea (13), Ataxia (7). Of the 92 reports with a coded outcome, Outcome Unknown is the leading category at 44.6%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on 114Mg Pyrantel Pamoate/ 114Mg Praziquantel.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial